# Reproductive Medicine Institute – FDA 483, Jun 9, 2026

Source: https://www.keypedia.com/records/483/reproductive-medicine-institute/63b9cddc-6be2-46f0-bf1d-13ec57a413ba

> FDA 483 for Reproductive Medicine Institute on June 09, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Reproductive Medicine Institute
- Inspection Date: 2026-06-09
- Product Type: other
- Office Name: Chicago District Office
- Summary: Reproductive Medicine Institute in Oak Brook, IL, a reproductive clinic, was cited for a significant labeling deficiency during an FDA inspection. The firm failed to prominently label donated fertilized oocytes (HCT/Ps) with required warning statements regarding communicable disease risk, particularly for those where donor eligibility determination was not required. This issue affected numerous reproductive tissues transferred between January 2024 and May 2026.

## Related Officers

- [David A. Moore](https://www.keypedia.com/people/david-a-moore/361e4fe8-caf0-4320-963a-3838616850e2)
- [FDA_PERSONNEL](https://www.keypedia.com/people/zoey-a-trombley/cb7ac4dd-bc47-4b51-8fef-a485b122c921)

Company: https://www.keypedia.com/companies/reproductive-medicine-institute/b3a4469f-9346-4e8b-81c0-b256c28b3031

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669